Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis

Nat Clin Pract Oncol. 2008 Apr;5(4):234-8. doi: 10.1038/ncponc1071. Epub 2008 Feb 19.

Abstract

Background: A 75-year-old man on methotrexate immunosuppression for myasthenia gravis presented with a 2-month history of lymphocytosis and bilateral inguinal adenopathy. There were no constitutional symptoms of fever, night sweats, or weight loss.

Investigations: Physical examination, blood tests, flow cytometry, fluorescent in situ hybridization, immunoglobulin gene sequencing, viral load quantification by real-time polymerase chain reaction, excisional lymph-node biopsy, bone-marrow biopsy, tumor morphology and immunohistochemistry, sequential CT and PET scans.

Diagnosis: Methotrexate-associated mantle-cell lymphoma.

Management: Cessation of methotrexate, anthracycline-based combination chemo-immunotherapy, and maintenance rituximab.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Lymphocytes
  • Lymphocytosis / chemically induced
  • Lymphoma, Mantle-Cell / chemically induced*
  • Lymphoma, Mantle-Cell / diagnosis
  • Lymphoma, Mantle-Cell / etiology
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Myasthenia Gravis / drug therapy*
  • Risk Factors

Substances

  • Immunosuppressive Agents
  • Methotrexate